1

'At least eight molecules will see clinical trials this year'

He appeared relaxed and more forthcoming than usual. Indeed, Glenmark is "two-to-three years ahead of the rest" in the Indian pharma space, the 38-year-old beamed. Read »
Created by deeksha Created 23 weeks 23 hours ago – Made popular 23 weeks 23 hours ago
Category: Business

User login